Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-12-03
1982-02-16
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, 422 61, G01N 3356, G01N 3348
Patent
active
043159087
ABSTRACT:
A method of determining human chorionic gonadotropin (HCG) in the urine. The urine to be tested is absorbed on an absorbent body. HCG is determined on the absorbent body by a radioimmunoassay method.
REFERENCES:
patent: 4016250 (1977-04-01), Saxena
patent: 4033723 (1977-07-01), Givner et al.
patent: 4071314 (1978-01-01), Prugnaud
patent: 4123509 (1978-10-01), Banik et al.
patent: 4138214 (1979-02-01), Givner
patent: 4200436 (1980-04-01), Mochida et al.
patent: 4208187 (1980-06-01), Givner
patent: 4234561 (1980-11-01), Bahl
Zer Avraham
Zer Tamar
LandOfFree
Method of determining human chorionic gonadotropin (HCG) in the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining human chorionic gonadotropin (HCG) in the , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining human chorionic gonadotropin (HCG) in the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-942578